Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases

Purpose of the study. A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Materials and methods. Patients with PV or ET, diagnosed according to the criteria WHO 2016 were included in the study....

Full description

Bibliographic Details
Main Authors: A L MELIKYAN, I N SUBORTSEVA, E A GILYAZITDINOVA, T I KOLOSHEJNOVA, E I PUSTOVAYA, E K EGOROVA, A M KOVRIGINA, A B SUDARIKOV, A O ABDULLAEV, E G LOMAIA, N T SIORDIYA, A Yu ZARITSKEY, V G SAVCHENKO
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2018-07-01
Series:Терапевтический архив
Subjects:
jak2v617f
ce-pegalpha-inf-α-2b
pegylated interferon alfa-2a / 2b
polycythemia vera
essential thrombocythemia
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32759/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/32759/pdf

Similar Items